GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Peter Lynch Fair Value

ACI Formulations (DHA:ACIFORMULA) Peter Lynch Fair Value : BDT39.27 (As of Apr. 27, 2024)


View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, ACI Formulations's PEG is 1. ACI Formulations's 5-Year TTM EBITDA Growth Rate is 7.44. ACI Formulations's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was BDT5.28. Therefore, the Peter Lynch Fair Value for today is BDT39.27.

As of today (2024-04-27), ACI Formulations's share price is BDT123.00. ACI Formulations's Peter Lynch fair value is BDT39.27. Therefore, ACI Formulations's Price to Peter Lynch Fair Value Ratio for today is 3.13.


The historical rank and industry rank for ACI Formulations's Peter Lynch Fair Value or its related term are showing as below:

DHA:ACIFORMULA' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 3.13   Med: 5.9   Max: 10.07
Current: 3.13


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of ACI Formulations was 10.07. The lowest was 3.13. And the median was 5.90.


DHA:ACIFORMULA's Price-to-Peter-Lynch-Fair-Value is ranked worse than
92.78% of 97 companies
in the Agriculture industry
Industry Median: 0.77 vs DHA:ACIFORMULA: 3.13

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


ACI Formulations Peter Lynch Fair Value Historical Data

The historical data trend for ACI Formulations's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations Peter Lynch Fair Value Chart

ACI Formulations Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.89 10.96 - - 26.23

ACI Formulations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 28.25 26.23 30.56 39.27

Competitive Comparison of ACI Formulations's Peter Lynch Fair Value

For the Agricultural Inputs subindustry, ACI Formulations's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACI Formulations's Price-to-Peter-Lynch-Fair-Value Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, ACI Formulations's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where ACI Formulations's Price-to-Peter-Lynch-Fair-Value falls into.



ACI Formulations Peter Lynch Fair Value Calculation

ACI Formulations's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 7.44 *5.278
=39.27

ACI Formulations's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT5.28.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


ACI Formulations  (DHA:ACIFORMULA) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 7.44 instead of 15 in this case.

ACI Formulations's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=123.00/39.27
=3.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACI Formulations Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of ACI Formulations's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ACI Formulations (DHA:ACIFORMULA) Business Description

Traded in Other Exchanges
N/A
Address
ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines